Profiel
Thomas E.
Jenkins is the founder of Elysium Therapeutics, Inc., founded in 2013, where the title held is Chief Scientific Officer.
Former job includes Chief Scientific Officer & Vice President-Research at Signature Therapeutics, Inc. Education history includes a doctorate from Stanford University and an undergraduate degree from the University of Akron.
Actieve functies van Thomas Jenkins
| Bedrijven | Functie | Begin |
|---|---|---|
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Oprichter | 01-01-2013 |
Eerdere bekende functies van Thomas Jenkins
| Bedrijven | Functie | Einde |
|---|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Thomas Jenkins
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Akron
University of Akron Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
















